Injective is a blockchain built for finance, offering a fully decentralized exchange infrastructure with cross-chain capabilities. The protocol enables anyone to create and trade on derivatives markets, prediction markets, spot exchanges, and more — without the permission or infrastructure traditionally required to launch financial products. What distinguishes Injective is its approach to eliminating barriers: zero gas fees for users, cross-chain trading (access assets from Ethereum, Cosmos, Solana, and other chains within Injective's unified order book), and a plug-and-play exchange infrastructure where developers can launch sophisticated trading platforms in hours rather than months. Injective's burn auction mechanism has made it one of the most deflationary tokens in crypto — 60% of all exchange fees are used to buy back and burn INJ from the open market weekly. This aggressive burn rate, combined with staking that locks ~60% of circulating supply, creates strong supply-demand dynamics.
Injective was founded by Eric Chen (Stanford) and Albert Chon (Stanford, former Amazon). The project launched its mainnet in November 2021 after incubation by Binance Labs. Injective has secured partnerships with major market makers and trading firms. The protocol has maintained a rapid development pace, adding new trading features and cross-chain integrations consistently. The burn auction mechanism has destroyed tens of millions of dollars worth of INJ since inception.
Injective is built on the Cosmos SDK with Tendermint consensus, achieving instant transaction finality. The chain features a fully decentralized order book that supports limit orders, market orders, and advanced order types at the protocol level. Cross-chain bridging through Injective Bridge connects assets from Ethereum, Cosmos IBC, Solana, and other networks. The burn auction occurs weekly: 60% of all trading fees collected by the protocol are pooled and auctioned off to the highest bidder, who pays in INJ. The winning bid's INJ is permanently burned. This mechanism creates consistent buy pressure and supply reduction proportional to trading activity.
INJ has a max supply of 100 million tokens with the burn auction continuously reducing circulating supply. Approximately 60% of supply is staked, locking it out of circulation. Staking yields approximately 15-17% APY from inflation rewards plus a share of transaction fees. The combination of high staking ratio and aggressive burns creates one of the tightest supply dynamics in crypto.
Weekly burn auctions have destroyed millions of INJ. With ~60% staked and ongoing burns, the effective circulating supply shrinks continuously.
Traders pay no gas — fees are embedded in trading spreads, creating a CEX-like experience with DEX self-custody benefits.
Trade assets from Ethereum, Cosmos, Solana, and other chains in a unified order book without manual bridging.
Anyone can launch new trading markets (derivatives, prediction markets, spot) without approval or infrastructure.
Despite strong technology, Injective's trading volume is modest compared to Solana DEXs or centralized exchanges.
While cross-chain capable, Injective's base in the Cosmos ecosystem limits its visibility compared to Ethereum or Solana-native projects.
15-17% APY is partially funded by inflation, which dilutes non-stakers. The real yield depends on fee revenue growth.
dYdX, Hyperliquid, and GMX compete aggressively for the decentralized derivatives market.
Every week, 60% of all trading fees collected on Injective are pooled. Anyone can bid INJ tokens to win the pool. The winning bidder's INJ is permanently burned. This creates consistent buy pressure and supply reduction. The burn rate accelerates as trading volume grows, making INJ more deflationary during periods of high activity.
INJ's ~15-17% APY comes from two sources: protocol inflation (new token creation for stakers) and a share of trading fees. The high rate incentivizes staking, which locks supply and reduces selling pressure. However, the inflation component dilutes non-stakers, so the real yield is the fee portion minus the dilution effect.
Both target decentralized derivatives but differ in approach. dYdX has higher volume and is more established for perpetual futures. Injective offers broader market types (derivatives, prediction markets, spot), cross-chain trading, and permissionless market creation. Injective's burn mechanism and higher staking yields differentiate its tokenomics.
View live Injective price, charts, and market data on the Injective detail page.
Learn how to purchase: How to Buy Injective